(Q43004112)
Statements
ITPA genotyping is not predictive for the development of side effects in AZA treated inflammatory bowel disease patients (English)
van Dieren JM
van Vuuren AJ
Kusters JG
Nieuwenhuis EE
Kuipers EJ
van der Woude CJ